FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine and concerns a local topical composition characterised by the fact that it contains synthetic lipoic acid; 95% ethyl alcohol; 1,2-propylene glycol, polyacrylic acid (any other hydrophilic gelling agent), triethanolamine, purified water; a method for preparing the local topical composition characterised by the fact that synthetic lipoic acid is dissolved while stirring in mixed ethyl alcohol and propylene glycol; at the same time polyacrylic acid is dispersed in a specified amount of water sufficient to reduce the ratio of the ingredients up to 100 wt %, after 3-hour swelling, the prepared solution is added to synthetic lipoic acid dissolved in mixed ethyl alcohol and propylene glycol and mixed up; the prepared composition is neutralised by a triethanolamine solution to pH 5.5-6.5 and mixed to form a light-yellow transparent gel-like mass.
EFFECT: group of inventions provides high antirheumatic, anti-inflammatory and analgesic activity, as well as effective antibacterial and anti-burn action.
4 cl, 4 ex, 1 tbl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
ANTI-INFLAMMATORY FORMULATION AND PROCESS FOR PREPARING THE SAME | 1989 |
|
RU2008002C1 |
COMPOSITIONS AND USE THEREOF FOR TREATING OR PREVENTING ROSACEA | 2017 |
|
RU2738932C2 |
HYDROPHILIC PHARMACEUTICAL COMPOSITION SHOWING ANTI-INFLAMMATORY EFFECT | 1999 |
|
RU2140258C1 |
METHOD OF TREATING PALMAR-PLANTAR ERYTHRODYSESTHESIA | 2018 |
|
RU2722396C2 |
PHARMACEUTICAL COMPOSITION POSSESSING ANTI-INFLAMMATORY AND ANALGESIC EFFECT AND METHOD FOR ITS PREPARING | 2006 |
|
RU2309738C1 |
PHARMACEUTICAL COMPOSITION FOR INFLAMMATION AND PAIN AND ITS PREPARATION METHOD (VERSIONS) | 2012 |
|
RU2604149C2 |
COMBINATION OF ALPHA-2-ADRENERGIC RECEPTOR AGONISTS AND NON-STEROID ANTI-INFLAMMATORY DRUG FOR TREATING OR PREVENTING INFLAMMATORY SKIN INJURY | 2010 |
|
RU2532388C2 |
AGENT OF PEPTIDE STRUCTURE POSSESSING ANTI-INFLAMMATORY, ANTIBACTERIAL, WOUND-HEALING, REGENERATIVE, ANALGESIC, BURNTREATING ACTION AND BASED DOSAGE FORMS | 2012 |
|
RU2517213C2 |
DRUG FOR TREATING OSTEOARTHROSIS (VERSIONS) | 2013 |
|
RU2538218C2 |
PHARMACEUTICAL COMPOSITION FOR ALLERGIC AND INFLAMMATORY SKIN DISEASES | 2009 |
|
RU2440108C2 |
Authors
Dates
2014-06-10—Published
2011-10-31—Filed